1. Rosenberg EB, Herberman RB, Levine PH, Halterman RH, McCoy JL, Wunderlich, JR.
Lymphocyte cytotoxicity reactions to leukemia-associated antigens in identical twins. Int
J Cancer 1972;9:648-58.
Oldham RK, Siwarski D, McCoy JL, Plata EJ Herberman RB. Evaluation of a cellmediated cytotoxicity assay utilizing 125iododeoxyuridine labeled tissue culture target cells. Natl Cancer Inst Monogr 1973;37:49-58.
Takasugi M, Mickey JR, Terasaki PI. Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res 1973;33:2898-902.
Rosenberg EB, McCoy JL, Green SS, Donnelly FC, Siwarski DF, Levine PH, Herberman RB. Destruction of human lymphoid tissue culture cell lines by human peripheral lymphocytes in 51Cr-release cellular cytotoxicity assays. J. Natl Cancer Inst 1974;52: 345-52.
Holtermann OA, Klein E, Casale GP. Selective cytotoxicity of peritoneal leucocytes for neoplastic cells. Cell Immunol 1973;9:339-52.
Nunn JE, Djeu JY, Glaser M, Lavrin DH, Herberman RB. Natural cytotoxic reactivity of rat lymphocytes against syngeneic Gross virus-induced lymphoma. J Natl Cancer Inst 1976;56:393-9.
Herberman RB, Nunn ME, Lavrin DH, Asofsky R. Effect of antibody to antigen on cellmediated immunity induced in syngeneic mice by murine sarcoma virus. J Natl Cancer Inst 1973;51:1509-12.
Herberman RB, Ting CC, Kirchner H, Holden H, Glaser M, Bonnard GD, et al. Effector mechanisms in tumour immunity. In: Brent, L and Holorow, J , editors. Prog Immunol Int Congr Immunol, 2nd 1974 Vol. 3 Amsterdam:North-Holland Publishing Co. 1974;285-95.
Herberman, RB, Nunn, ME and Lavrin, DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors I. Distribution of reactivity and specificity. Int J Cancer 1975;16:216-29.
Kiessling R, Klein E, Wigzell H. "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol 1975;5:112-7.
Herberman RB, Gaylord CE. Conference and workshop on cellular immune reactions to human tumor-associated antigens. Natl Cancer Inst Monogr 1973;37:1-221. Herberman RB, Holden HT. Natural cell-mediated immunity. Adv Cancer Res 1978;27: 305-77.
Herberman RB. Natural Cell-Mediated Immunity Against Tumors New York:Academic Press 1980.
Herberman RB. Natural Killer Cells and Other Natural Effector Cells. New York: Academic Press, 1982.
Herberman RB, Ortaldo JR. Natural killer cells: their role in defenses against disease Science 1981;214:24-30.
Timonen T, Ortaldo JR, Herberman RB. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med 1981 ;153:569—82. Reynolds CW, Timonen T, Herberman RB. Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells. J Immunol 1981 ;127:292—87. Lanier LL, Cwirla S, Federspiel N. Human natural killer cells isolated from peripheral blood do not rearrange T cell antigen receptor beta chain genes. J Exp Med 1986; 163: 200-14.
Chambers WH, Vujanovic NL, DeLeo AB, Olszowy MW, Herberman RB, Hiserodt JC. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J Exp Med 1989;169:1373-89.
Sentman CL, Kumar V, Koo G, Bennett M. Effector cell expression of NK1.1, a murine natural killer cell-specific molecule, and ability of mice to reject bone marrow allografts. J Immunol 1989;142:1847-53.
Vujanovic NL, Nagashima S, Herberman RB, Whiteside TL. Non-secretory apoptotic killing by human natural killer cells. J Immunol 1966; 157:1117-26.
Trinchieri G. Biology of natural killer cells Adv Immunol 1989;47:187-376.
Moretta L, Ciccone E, Pende D, Tripodi G, Bottino C, Moretta A. Human natural killer cells: clonally distributed specific functions and triggering surface molecules. Lab Invest
Moretta A, Vitle M, Bottino C, Orengo AM, Morelli L, Augugliaro R, et al. p58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med 1993; 178: 597-604.
Storkus WJ, Alexander J, Payne JA, Cresswell P, Dawson JR. The alpha 1 /alpha 2 domains of class IHLA molecules, confer resistance to natural killing. J Immunol 1989; 143:3853— 7.
Storkus WJ, Suiter RD, Alexander J, Ward FE, Ruiz RE, Cresswell P, et al. Class I induced resistance to natural killing: identification of nonpermissive residues in HLA-A2. Proc Natl Acad Sci USA 1991 ;88:5989-92.
Herberman RB. Immunoregulation and natural killer cells. Mol Immunol 1982; 19:131321.
Herberman RB, Ortaldo JR, Bonnard GD. Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity. Nature 1979;277:221-3. Kuribayashhi K, Gillis S, Kern DE, Henney CS. Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity. J Immunol 1981; 126: 2321-7.
Ortaldo JR, Mason A, Overton R. Lymphokine-activated killer cells: analysis of progenitors and effectors. J Exp Med 1986; 164:1193-205.
Vujanovic NL, Rabinowich H, Lee YJ, Jost L, Herberman RB, Whiteside TL. Distinct phenotypic and functional characteristics of human natural killer cells obtained by rapid interleukin-2-induced adherence to plastic. Cell Immunol 1993;151:133-57
Vitolo D, Vujanovic N, Rabinowich H, Schlesinger M, Herberman RB, Whiteside, TL.
Rapid interleukin-2-induced adherence of human natural killer (NK) cells. II Expression of mRNA for cytokines and IL-2 receptors in adherent NK cells. J Immunol 1993;151:
Was this article helpful?
Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.